WA
LGND icon

WPG Advisers’s Ligand Pharmaceuticals LGND Stock Holding History

WPG Advisers’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.48K Hold
11
– – ﹤0.01% 1064
2026
Q1 		$2.2K Hold
11
– – ﹤0.01% 1059
2025
Q4 		$2.08K Hold
11
– – ﹤0.01% 1118
2025
Q3 		$1.95K Hold
11
– – ﹤0.01% 1145
2025
Q2 		$1.25K Sell
11
-4
-27% -$428 ﹤0.01% 1220
2025
Q1 		$1.58K Hold
15
– – ﹤0.01% 1173
2024
Q4 		$1.61K Buy
+15
New +$1.7K ﹤0.01% 1125

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

WPG Advisers's LGND Position: Q2 2026 in Review

WPG Advisers held its Ligand Pharmaceuticals (LGND) position steady in Q2 2026 at 11 shares worth $3.48K. The position accounts for ﹤0.01% of the portfolio, ranked #1064.

WPG Advisers first reported a position in LGND in Q4 2024 and has held it in 7 quarters since. 417 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • WPG Advisers held 11 shares of Ligand Pharmaceuticals worth $3.48K as of Q2 2026.
  • WPG Advisers left its Ligand Pharmaceuticals share count unchanged in Q2 2026.
  • Ligand Pharmaceuticals made up ﹤0.01% of WPG Advisers's portfolio in Q2 2026, its #1064 holding.
  • WPG Advisers first reported a position in Ligand Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 417 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.